• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Systematic screening for atrial fibrillation may reduce morbidity and mortality in older patients

byNeel MistryandTeddy Guo
November 2, 2021
in Cardiology, Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. There were significantly fewer events in the intervention group (5.45 per 100 years) compared to control (5.68 per 100 years; p=0.045).

2. The number needed to invite to screen to prevent the composite primary outcome was 91.

Evidence Rating Level: 1 (Excellent)

Study Rundown: There is strong association between atrial fibrillation and cardioembolic stroke. It is believed that early management of patients with atrial fibrillation (AFib) may reduce morbidity and mortality. Until now, little research has been conducted in this domain. This randomized controlled trial aimed to determine whether timely screening for AFib affects the incidence of stroke, systemic embolism, and all-cause mortality. Co-primary endpoints included 5-year incidence of ischemic or hemorrhagic stroke, systemic embolism, severe bleeding, and all-cause mortality. Individuals were given the choice of management with oral anticoagulants if AFib was suspected on screening. According to results, significantly fewer primary endpoint events occurred among individuals screened for AFib compared to those who were not. This study was strengthened by a long follow-up, large sample size, and inclusion of individuals at high-risk of cardiovascular disease.

Click to read the study in The Lancet

Relevant Reading: Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

In-depth [randomized controlled trial]: Between Mar 1, 2012, and May 28, 2014, 28 768 patients were assessed for eligibility. Included were patients living in Halland and Stockholm between 75 and 76 years of age. Enrolled participants were followed for a minimum of 5 years. Altogether, 27 975 patients (13 979 in screening group and 13 996 in control group) were included in the analysis. With regard to the primary endpoint, significantly fewer events occurred in the AFib screening group (5.45 events per 100 years, 95% confidence interval [CI] 5.52-5.61) compared to control (5.68 events per 100 years, 95% CI 5.52-5.85, hazard ratio 0.96, p=0.045). However, there were no significant differences between the groups with respect to the individual components of the composite primary outcome. Furthermore, all-cause death comprised the majority of adverse events (71.2%), followed by severe bleeding (31.7%), ischemic stroke (17.6%), hemorrhagic stroke (3.2%), and systemic embolism. Overall, findings from this study suggest that early screening and timely management of atrial fibrillation in older patients may prevent further complications.

RELATED REPORTS

CYP2C19 loss-of-function carriers have modest benefit from ticagrelor and aspirin following cerebrovascular event: CHANCE-2 Trial

Magnetic resonance imaging-guided fibrosis ablation plus pulmonary vein isolation non-superior to pulmonary vein isolation alone in preventing atrial arrhythmia recurrence: The DECAAF II trial

ANNEXA-A and ANNEXA-R trials: Andaxanet Alfa for Reversal of Apixaban and Rivaroxaban [Classics Series]

Image: PD 

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: afibanticoagulationarrhythmiasatrial fibrillationCardiac Arrhythmiascardiologydisease screeningelderlyembolic strokeischemic strokestroke risk
Previous Post

COVID-19-related hospital policies not associated with delays in urgent open and closed fracture surgeries compared to pre-pandemic

Next Post

Phototherapy not associated with increased risk of childhood cancer

RelatedReports

Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Chronic Disease

CYP2C19 loss-of-function carriers have modest benefit from ticagrelor and aspirin following cerebrovascular event: CHANCE-2 Trial

June 23, 2022
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Magnetic resonance imaging-guided fibrosis ablation plus pulmonary vein isolation non-superior to pulmonary vein isolation alone in preventing atrial arrhythmia recurrence: The DECAAF II trial

June 22, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Critical, Emergent and Pulmonary Care Classics

ANNEXA-A and ANNEXA-R trials: Andaxanet Alfa for Reversal of Apixaban and Rivaroxaban [Classics Series]

June 21, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Critical, Emergent and Pulmonary Care Classics

RE-VERSE AD Trial: Idarucizumab for the Reversal of Anticoagulation by Dabigatran [Classics Series]

June 20, 2022
Next Post
Poverty, preterm birth demonstrate additive effect on cognition

Phototherapy not associated with increased risk of childhood cancer

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Respiratory fluroquinolone treatment associated with increased short-term risk of sudden cardiac death compared to amoxicillin-based antibiotics

Compliance-linked incentives increase infant immunizations rates in rural India

Compared to prior infection, prior vaccination is associated with greater neutralization capacity against all COVID-19 variants

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.